History | Luspatercept for treating anaemia caused by myelodysplastic syndromes (terminated appraisal) | Guidance | NICE

History

Invitation to participate

Final scope (PDF 169 KB)

Published:

07 November 2019
Final stakeholder list (PDF 180 KB)

Published:

07 November 2019
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 215 KB)

Published:

07 November 2019
Equality Impact Assessment (Guidance development) (PDF 123 KB)

Published:

07 November 2019

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope pre referral (PDF 227 KB)

Published:

04 June 2019
Draft matrix pre referral (PDF 180 KB)

Published:

04 June 2019